Comparative biochemical assessment of chronic renal failure in male and female patients

S. A. Abdulla; H. A. H. Abdulrahman; M. A. Abdulwahab; R. J. Mansoor; M. J. I. Al-Shammari

doi:10.15421/0226018

S. A. Abdulla College of Science
H. A. H. Abdulrahman College of Science
M. A. Abdulwahab College of Science
R. J. Mansoor College of Science
M. J. I. Al-Shammari College of Education for Pure Science

Keywords: chronic kidney disease, biochemical markers, calcium, phosphate, gender differences, renal function.

Abstract

Failure of the kidneys to eliminate waste materials and maintain an internal balance of water and salts in the body is referred to as renal failure. In this research, individuals with renal failure were studied from during September 2023 at the Ibn Sina C enter for H emodialysis in Baqubah T eaching H ospital in Diyala province. This study included 44 samples from patients (males) with kidney failure, and the different variables compared with the same variables in 44 females. During this study, some hematological variables were examined, which included the concentration of hemoglobin, and biochemical variables in the blood such as the concentration of albumin. We aimed to determine the most significant physiological changes associated with renal failure and to compare the results. In patients with renal failure, the hemogl o bin concentration in males was found to be no t significantly different from that in females individuals. The albumin level was shown to be no t statistically significant. A ccording to the findings comparing males and females, c hronic renal illness has been shown to have a detrimental influence on the majority of physiological and biochemical variables examined in this research.

References

Agarwal, A. K. (2021). Iron metabolism and management: Focus on chronic kidney disease. Kidney International Supplements, 11(1), 46–58.

Ahmed, A. W., Abdul-QaderKhuder, H., Jasim, S. A. H., & Mohsein, O. A. (2025). Hormonal profiles and metabolic changes in women diagnosed with concomitant Hashimoto’s thyroiditis and polycystic ovary syndrome via sonography. European Journal of Clinical and Experimental Medicine, 23(3), 596–604.

Babitt, J. L., & Lin, H. Y. (2012). Mechanisms of anemia in CKD. Journal of the American Society of Nephrology, 23(10), 1631–1634.

Beddhu, S., Ma, X., Baird, B., Cheung, A. K., & Greene, T. (2009). Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clinical Journal of the American Society of Nephrology, 4(11), 1805–1810.

Cecchi, S., Di Stante, S., Belcastro, S., Bertuzzi, V., Cardillo, A., Diotallevi, L., Grabocka, X., Kulurianu, H., Martello, M., Nastasi, V., Paci Della Costanza, O., Pizzolante, F., & Di Luca, M. (2023). Supplemented very low protein diet (sVLPD) in patients with advanced chronic renal failure: Clinical and economic benefits. Nutrients, 15(16), 3568.

Cheng, T., Wang, X., Han, Y., Hao, J., Hu, H., & Hao, L. (2023). The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease. BMC Nephrology, 24, 57.

Drechsler, C., Verduijn, M., Pilz, S., Krediet, R. T., Dekker, F. W., Wanner, C., Ketteler, M., Boeschoten, E. W., & Brandenburg, V. (2011). Bone alkaline phosphatase and mortality in dialysis patients. Clinical Journal of the American Society of Nephrology, 6(7), 1752–1759.

Fukui, M., Tanaka, M., Yamazaki, M., Hasegawa, G., Nishimura, M., Iwamoto, N., Ono, T., Imai, S., & Nakamura, N. (2010). Low serum bilirubin concentration in haemodialysis patients with type 2 diabetes. Diabetic Medicine, 28(1), 96–99.

Garibotto, G., Sofia, A., Saffioti, S., Bonanni, A., Mannucci, I., & Verzola, D. (2010). Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clinical Nutrition, 29(4), 424–433.

Hasan, N., Nasser, N. A., Hussein, A. D., & Mohsein, O. A. (2024). Effect of electronic smoking (vaping) on thyroid hormones level and lipid profile in men. The Ukrainian Biochemical Journal, 96(5), 55–64.

Hassab, Z. S., & Merzah, K. S. (2023). Biochemical markers level in Iraqi renal failure patients on hemodialysis. Latin American Journal of Pharmacy, 42, 290–294.

Kellum, J. A., Unruh, M. L., & Murugan, R. (2011). Acute kidney injury. BMJ Clinical Evidence, 2011, 2001.

Khan, M. N., & Elderdery, A. (2018). Alterations of hematological parameters, hemoglobin and hematocrit with liver enzymes, aspartate transaminase and alanine transaminase among patients with chronic kidney disease undergoing hemodialysis in Aljouf Region, Saudi Arabia. Journal of Hematology, 7(1), 1–6.

Kim, S. H., Shin, K., Moon, S., Jang, J., Kim, H. S., Suh, J., & Yang, W. (2017). Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Medicine, 6(6), 1311–1322.

Lateef, D., Nasser, N., & Mohsein, O. (2024). The relationships between Aplein, Vaspin and thyroid hormone levels in obese diabetic and non-diabetic women. Journal of Experimental and Clinical Medicine, 41(2), 239–245.‏

Li, J.-W., Xu, C., Fan, Y., Wang, Y., & Xiao, Y.-B. (2014). Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis. PLoS One, 9(7), e102276.

Meyer, T. W., & Hostetter, T. H. (2007). Uremia. New England Journal of Medicine, 357, 1316–1325.

Naif, N. H., Ahmed, E. M., Thamer, N. A., & Muhsein, O. A. (2025). The impact of inflammatory and adipokine biomarkers on breast cancer progression and patient outcomes. Bulletin of Pharmaceutical Sciences Assiut University, 48(1), 511–522.

Park, J. B., Kang, D. Y., Yang, H. M., Cho, H. J., Park, K. W., Lee, H. Y., Kang, H. J., Koo, B. K., & Kim, H. S. (2013). Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. European Heart Journal, 34(12), 920–931.

Pecoits-Filho, R., Abensur, H., Betônico, C. C. R., Machado, A. D., Parente, E. B., Queiroz, M., Salles, J. E. N., Titan, S., & Vencio, S. (2016). Interactions between kidney disease and diabetes: Dangerous liaisons. Diabetology and Metabolic Syndrome, 8, 50.

Prough, D. S. (2000). Physiologic acid-base and electrolyte changes in acute and chronic renal failure patients. Anesthesiology Clinics of North America, 18(4), 809.

Regidor, D. L., Kovesdy, C. P., Mehrotra, R., Rambod, M., Jing, J., McAllister, C. J., Van Wyck, D., Kopple, J. D., & Kalantar-Zadeh, K. (2008). Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. Journal of the American Society of Nephrology, 19(11), 2193–2203.

Ryu, S., Chang, Y., Zhang, Y., Woo, H.-Y., Kwon, M.-J., Park, H., Lee, K.-B., Son, H. J., Cho, J., & Guallar, E. (2014). Higher serum direct bilirubin levels were associated with a lower risk of incident chronic kidney disease in middle aged Korean men. PLoS One, 9(2), e75178.

Shukr, M. F., & Hamad, M. S. (2025). A study of some biochemistry parameters in blood serum of patients with chronic renal failure. E3S Web of Conferences, 621, 02001.

Targher, G., Zoppini, G., Cesare Guidi, G., & Lippi, G. (2009). Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. Kidney International, 75(8), 863.

Wang, J., Wang, B., Liang, M., Wang, G., Li, J. P. J., Zhang, Y., Huo, Y., Cui, Y., Xu, X., & Qin, X. (2018). Independent and combined effect of bilirubin and smoking on the progression of chronic kidney disease. Clinical Epidemiology, 10, 121–132.